Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 31, 2014

VELOSO v. APLIN et al

Track this case

Case Number:

1:14-cv-01787

Court:

Indiana Southern

Nature of Suit:

160(Stockholders Suits)

Multi Party Litigation:

Derivative Litigation

Judge:

Judge Sarah Evans Barker

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. November 05, 2014

    Endocyte Investor Sues Over Faulty Drug In $1B Merck Deal

    Endocyte Inc.'s board of directors lied about an ineffective cancer drug at the heart of a $1 billion deal with Merck & Co. to inflate the company's stock ahead of a public offering, according to an investor's derivative suit recently filed in Indiana federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login